Planning Grants for Translating Chronic Kidney Disease (CKD) Research into Improved Clinical Outcomes (R34)

Post Date

September 15th 2010

Application Due Date

February 28th 2011

Funding Opportunity Number

RFA-DK-10-011

CFDA Number(s)

93.847

Funding Instrument Type(s)

Grant

Funding Activity Categories

Food and Nutrition
Health

Number of Awards

4

Eligibility Categories

State Governments
County Governments
City or Township Governments
Special District Governments
Independent School Districts
Public and State Controlled Institutions of Higher Education
Federally Recognized Native American Tribal Governments
Public Housing Authorities or Indian Housing Authorities
Non-Federally Recognized Native American Tribal Organizations
Non-Profits With 501 (c) (3) Status With The IRS (Except Higher Education Institutions)
Non-Profits Without 501 (c) (3) Status With The IRS (Except Higher Education Institutions)
Private Institutions of Higher Education
For-Profit Organizations (Except Small Businesses)
Small Businesses
Other

Other Eligible Applicants include the following: Alaska Native and Native Hawaiian Serving Institutions; Eligible Agencies of the Federal Government; Faith-based or Community-based Organizations; Hispanic-serving Institutions; Historically Black Colleges and Universities (HBCUs); Indian/Native American Tribal Governments (Other than Federally Recognized); Regional Organizations; Tribally Controlled Colleges and Universities (TCCUs) ; U.S. Territory or Possession.

Funding

• Estimated Total Funding:

  $1400000

• Award Range:

  $None - $None

Grant Description

The National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK) encourages NIH Clinical Trial Planning Grant (R34) applications from institutions/organizations to test the effectiveness of interventions for the prevention, treatment and management of chronic kidney disease (CKD) that have a high likelihood of being widely adopted, and sustained in a wide range of health care settings and in individuals and communities at highest risk. The approaches to be tested must be based on interventions previously demonstrated to be efficacious in randomized clinical trials, and widely accepted throughout the chronic kidney disease CKD community. The proposed research must target chronic kidney disease and/or its complications.

Contact Information

• Agency

  Department of Health and Human Services

• Office:

  National Institutes of Health

• Agency Contact:

  NIH OER Webmaster
  FBOWebmaster@OD.NIH.GOV
  

• Agency Mailing Address:

  If you have any problems linking to this funding announcement, please contact the NIH OER Webmaster

• Agency Email Address:

  FBOWebmaster@OD.NIH.GOV

• More Information:

  http://grants.nih.gov/grants/guide/rfa-files/RFA-DK-10-011.html